NDC50419-0192-85: DIATRIZOATE MEGLUMINE INJECTION.
DIATRIZOATE MEGLUMINE INJECTION. Key specifications include administration: INTRAVENOUS, special_features: WITH VENTED SET; FOR INTRAVENOUS USE ONLY, primary_container_type: BOTTLE, pharmaceutical_vehicle_type: AQUEOUS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 150.000 MILLILITERS. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-333-6656, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS |
| special_features | WITH VENTED SET; FOR INTRAVENOUS USE ONLY |
| primary_container_type | BOTTLE |
| pharmaceutical_vehicle_type | AQUEOUS |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 1 |
| primary_container_content_quantity | 150.000 MILLILITERS |
| active_medicament_medicinal_strength | 60.000 PERCENTAGE, W/V DIATRIZOATE MEGLUMINE ACTIVE INGREDIENT |
| NSN | 6505-01-333-6656 |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 150.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | WITH VENTED SET; FOR INTRAVENOUS USE ONLY |
| PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 60.000 PERCENTAGE, W/V DIATRIZOATE MEGLUMINE ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 1 |
No substitute or cross-reference records for this part.